HPLC-MART
Sign in with Google
Product no. 105183-2115 Active
Get quote
Catalog Search results 105183-2115

105183-2115

Back to results All columns of this brand
105183-2115
Order / Price
Price on request

Sepax Bio 200 C18

by Sepax Technologies

Sepax Bio-C18 Capillary Columns                 

  • Most comprehensive selection of the stationary phases
  • Pioneered sub-2 µm PS/DVB based ion-exchange phases
  • Combined high efficiency and high capacity for non-porous Proteomix ion-exchange phases
  • High speed, high recovery and high stability
  • Column ID selection of 75, 150, and 300 µm and length selection of 5, 10 and 15 cm
Application areas:
Peptides Pharmaceutical molecules Proteins
Specification
Vendor Sepax Technologies Internal Diameter
Brand Sepax Bio 200 C18 Pore size 200
Modifification Silica/C18 Surface Area 200
Mode Reversed-Phase Carbon Load, % 10.0
Particle Size Endcapped Yes
Length Product usage Pharmaceutical molecules
Similar columns Columns with same mode & modification — across all brands
VendorBrandModeModification Int. diam.LengthParticlesPoresPrice
Teknokroma Advantix ODS Reversed-Phase Silica/C18 4.6 mm 200 mm 5.0 μm — On request
Thermo Fisher Scientific Acclaim Reversed-Phase Silica/C18 2.1 mm 50 mm 2.2 μm 120 Å On request
ACE ACE C18-HL Reversed-Phase Silica/C18 3.0 mm 125 mm 3.0 μm 90 Å On request
Princeton Chromatography Inc. PrincetonSPHER OMNI C18-60 Reversed-Phase Silica/C18 7.8 mm 150 mm 5.0 μm 60 Å On request
SiliCYCLE SiliaChrom AQ C18 Reversed-Phase Silica/C18 20.0 mm 50 mm 10.0 μm 100 Å On request
ACE ACE Super C18 Reversed-Phase Silica/C18 2.1 mm 30 mm 5.0 μm 90 Å On request
Merck Purospher® STAR Reversed-Phase Silica/C18 4.0 mm 30 mm 3.0 μm 120 Å On request
GRACE VisionHT C18 Polar Reversed-Phase Silica/C18 7.0 mm 33 mm 1.5 μm 100 Å On request
Customer feedback

No customer reviews yet. Be the first to share your experience!

Back to search results
Advertise With Us

Reach thousands of HPLC scientists and researchers. Fill in your details and our team will contact you shortly.